A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
145: ID/KLH active immunotherapy (FAVID®) following high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for non-hodgkin's lymphoma (NHL)
2007
Biology of Blood and Marrow Transplantation
prior to mobilization and progression free survival as well as overall survival. Conclusion: We conclude that 1) degree of plasma cell BM infiltration before mobilization did not predict for transplant outcomes and 2) increased plasma cell BM infiltration before mobilization adversely affect the efficiency of stem cell mobilization. Thus, pre-transplant cytoreductive therapy improves stem cell collection efficiency but did not affect the transplant outcomes.
doi:10.1016/j.bbmt.2006.12.149
fatcat:snujv2vchfbr3pqup733gqnxua